|
|
|
|
| Introducing a new way to source solutions for improving, refining, and optimizing your CGT manufacturing! From April 8-10, Life Science Connect brings you the next virtual showcase from its network of trusted communities: Cell & Gene Therapy Tech Expo. Simply bring your attention, questions, and manufacturing requirements (no travel, cost, or inconvenience!) and experience this unique opportunity to learn about the latest technologies in CGT manufacturing and how they can help solve your biggest challenges. |
|
|
|
Webinar | Lonza | Review a scalable suspension-based Lenti production platform using a proprietary HEK293T clonal cell line and improvement steps to generate commercially viable therapies from concept to patient. |
|
|
|
Webinar | Andelyn Biosciences | Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified. |
|
|
|
Video | Invetech | Overcoming commercial manufacturing challenges in cell and gene therapy with innovative solutions, scalable processes, and advanced technologies to ensure efficiency, quality, and regulatory compliance. |
|
|
|
Webinar | inSeption Group | Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners. |
|
|
|
Webinar | Terumo BCT | Generate GMP-compliant mesenchymal stem cells (MSCs) at scale with a closed, automated workflow. Learn how to optimize MSC harvest yields and ensure trilineage differentiation. |
|
|
|
Webinar | Aldevron | Explore how tailored manufacturing solutions can enhance program outcomes, leverage cutting-edge technologies for research and discovery, and optimize preclinical applications. |
|
|
|
Webinar | PBS Biotech, Inc. | Discover a highly scalable, microcarrier-based 3D culture process designed for the efficient expansion of human induced pluripotent stem cells (hiPSCs) up to 10 liters. |
|
|
|
Video | Applied StemCell | Using cells with a pre-engineered TARGATT™ landing pad, we achieve inducible expression within just 4-6 weeks after donor plasmid creation, significantly reducing development time and effort. |
|
|
|
Video | Sartorius | Cell Insights by Umetrics® Studio simplifies advanced data analytics for bioprocessing, offering hybrid modeling, and cell insights to streamline development, and support data-driven decisions. |
|
|
|
Webinar | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | Explore the essential role of apheresis in obtaining high-quality cellular material for advanced therapies. Learn how optimized collection processes, donor selection, and handling techniques make an impact. |
|
|
